Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio
In a big year for contract manufacturers, Massachusetts’ Thermo Fisher Scientific has emerged as a leading partner for drugmakers fighting the Covid-19 pandemic, particularly in diagnostics and therapeutics. Now, buoyed by that success and looking to scale up its vaccine offerings, Thermo Fisher is plotting big expansion across its global portfolio.
Thermo Fisher will expand its facilities in Greenville, NC; Ferentino and Monza, Italy; and Swindon, England, to expand its range of offerings for customers”whether it’s an emerging biotech working on a vaccine for a novel virus or a high-volume pharmaceutical manufacturer delivering necessary medicines at scale,” a spokesperson told Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.